Business Context and Reporting Period
This Form 8-K filing by Silicon Valley Acquisition Corp. (SVAQ) reports on events occurring between December 24, 2025, and January 7, 2026. The Company, a Cayman Islands-based special purpose acquisition company (SPAC), consummated its initial public offering (IPO) and subsequently closed the partial exercise of the underwriters' over-allotment option.
Key Financial Metrics
- Initial IPO Proceeds: $200,000,000 from the sale of 20,000,000 Units at $10.00 per Unit.
- Over-Allotment Proceeds: $15,000,000 from the sale of 1,500,000 additional Units at $10.00 per Unit.
- Total Public Proceeds: $215,000,000.
- Private Placement Proceeds: $6,550,000 total ($6,250,000 from initial 625,000 units and $300,000 from 30,000 additional units) sold to the Sponsor and Clear Street LLC.
- Trust Account Funding: $15,000,000 from the over-allotment closing was deposited into a U.S.-based trust account maintained by Equiniti Trust Company, LLC.
- Warrant Exercise Price: $11.50 per share.
Material Changes
The primary material change reported is the partial exercise of the 45-day over-allotment option by the underwriters. On January 5, 2026, the underwriters elected to purchase 1,500,000 of the available 3,000,000 over-allotment units. This transaction closed on January 7, 2026, increasing the total number of public units sold and the capital raised by the Company.
Guidance, Outlook, and Management Commentary
The filing does not provide forward-looking guidance, earnings outlook, or specific management commentary regarding future business strategy beyond the completion of the capital raise. The document focuses strictly on the mechanics of the IPO closing and the over-allotment exercise. No risks or contingencies are detailed in this specific report other than the standard incorporation of the underwriting agreements.
Investor Verification Checklist
- Verify the total number of outstanding Class A ordinary shares and warrants following the over-allotment closing.
- Confirm the total amount of funds currently held in the trust account for public shareholders.
- Review the attached amendments to the Underwriting Agreement and Private Placement Units Purchase Agreements for any changes to redemption rights or warrant terms.
- Check the press release (Exhibit 99.1) for any additional details on the use of proceeds or timeline for identifying a target acquisition.